New guidelines for breast cancer screening in US women

JAMA - Journal of the American Medical Association

Volumn 314, Issue 15, 2015, Pages 1569-1571

  Keating, Nancy L ^a,b   Pace, Lydia E ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BREAST CANCER; BREAST EXAMINATION; CANCER MORTALITY; CANCER SCREENING; DECISION MAKING; EVIDENCE BASED PRACTICE; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH INSURANCE; HIGH RISK PATIENT; HUMAN; INTRADUCTAL CARCINOMA; LIFE EXPECTANCY; MAMMOGRAPHY; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; BREAST TUMOR; ECHOGRAPHY; STANDARDS;

BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY;

EID: 84944550806     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.13086     Document Type: Review

References (27)

1. Oeffinger KC, Fontham ETH, Etzioni R, et al. Breast cancer screening for women at average risk. JAMA. doi:10.1001/jama.2015.12783.
2. American Cancer Society. http://www.cancer.org. Accessed September 15, 2015.
3. Brawley O, Byers T, Chen A, et al. New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA. 2011;306(22): 2495-2499.
4. US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-726, W-236.
5. Draft recommendation statement: breast cancer screening. http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementDraft/breast-cancer-screening1. Accessed September 18, 2015.
6. Myers ER, Moorman P, Gierisch JM, et al. Benefits and harms of breast cancer screening. JAMA. doi:10.1001/jama.2015.13183.
7. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; US Preventive Services Task Force. Screening for breast cancer. Ann Intern Med. 2009;151(10):727-737, W237-42.
8. Miglioretti D, Zhu W, Kerlikowske K, et al. Breast tumor prognostic characteristics and biennial vs annual mammography, age, and menopausal status. JAMA Oncol. doi:10.1001/jamaoncol.2015 .3084.
9. Kerlikowske K, Zhu W, Hubbard RA, et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013;173(9): 807-816.
10. Parvinen I, Chiu S, Pylkkänen L, et al. Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40-49 in Finland. Br J Cancer. 2011;105(9):1388-1391.
11. Michaelson JS, Silverstein M, Wyatt J, et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer. 2002;95(4): 713-723.
12. Hubbard RA, Kerlikowske K, Flowers CI, et al. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography. Ann Intern Med. 2011;155(8):481-492.
13. Virnig BA, Shamliyan T, Tuttle TM, Kane RL, Wilt TJ. Diagnosis and Management of Ductal Carcinoma in Situ (DCIS). Rockville, MD: Agency for Healthcare Research and Quality; 2009.
14. Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ [published online August 20, 2015]. JAMA Oncol. doi:10.1001/jamaoncol.2015.2510.
15. Shapiro S, Venet W, Straqux P, Venet L, eds. Periodic Screening for Breast Cancer: The Health Insurance Plan Project and Its Sequelae, 1963-1986. Baltimore, MD: Johns Hopkins University Press; 1988.
16. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet. 1999;353 (9168):1903-1908.
17. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013;6(6):CD001877.
18. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2. J Natl Cancer Inst. 2000;92(18):1490-1499.
19. Oestreicher N, Lehman CD, Seger DJ, Buist DS, White E. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. AJR Am J Roentgenol. 2005;184(2):428-432.
20. Boulos S, Gadallah M, Neguib S, et al. Breast screening in the emerging world. Breast. 2005;14 (5):340-346.
21. Mittra I, Mishra GA, Singh S, et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India. Int J Cancer. 2010;126(4):976-984.
22. Sankaranarayanan R, Ramadas K, Thara S, et al. Clinical breast examination. J Natl Cancer Inst. 2011;103(19):1476-1480.
23. Barton MB, Harris R, Fletcher SW. Does this patient have breast cancer [The Rational Clinical Examination]? JAMA. 1999;282(13):1270-1280.
24. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327-1335.
25. Elmore JG, Kramer BS. Breast cancer screening. JAMA. 2014;311(13):1298-1299.
26. Schonberg MA, Hamel MB, Davis RB, et al. Development and evaluation of a decision aid on mammography screening for women 75 years and older. JAMA Intern Med. 2014;174(3):417-424.
27. Hersch J, Barratt A, Jansen J, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening. Lancet. 2015;385(9978):1642-1652.